81 related articles for article (PubMed ID: 17347485)
1. Darbepoetin-alpha does not promote microvascular thrombus formation in mice: role of eNOS-dependent protection through platelet and endothelial cell deactivation.
Lindenblatt N; Menger MD; Klar E; Vollmar B
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1191-8. PubMed ID: 17347485
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis.
Momi S; Caracchini R; Falcinelli E; Evangelista S; Gresele P
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):820-9. PubMed ID: 24558107
[TBL] [Abstract][Full Text] [Related]
3. Systemic hypothermia increases PAI-1 expression and accelerates microvascular thrombus formation in endotoxemic mice.
Lindenblatt N; Menger MD; Klar E; Vollmar B
Crit Care; 2006; 10(5):R148. PubMed ID: 17062126
[TBL] [Abstract][Full Text] [Related]
4. Darbepoetin-alpha enhances hepatectomy-associated stimulation of colorectal liver metastatic growth.
Rupertus K; Sperling J; Corsten M; Scheuer C; Nickels RM; Schilling MK; Menger MD; Kollmar O
Ann Surg; 2010 Jul; 252(1):131-41. PubMed ID: 20531003
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressants accelerate microvascular thrombus formation in vivo: role of endothelial cell activation.
Püschel A; Lindenblatt N; Katzfuss J; Vollmar B; Klar E
Surgery; 2012 Jan; 151(1):26-36. PubMed ID: 22019501
[TBL] [Abstract][Full Text] [Related]
6. Essential role of bone marrow for microvascular endothelial and metabolic functions in mice.
Nakajima S; Ohashi J; Sawada A; Noda K; Fukumoto Y; Shimokawa H
Circ Res; 2012 Jun; 111(1):87-96. PubMed ID: 22550140
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin requires endothelial nitric oxide synthase to counteract TNF-[alpha]-induced microcirculatory dysfunction in murine striated muscle.
Contaldo C; Lindenblatt N; Elsherbiny A; Högger DC; Borozadi MK; Vetter ST; Lang KS; Handschin AE; Giovanoli P
Shock; 2011 Mar; 35(3):315-21. PubMed ID: 20926979
[TBL] [Abstract][Full Text] [Related]
8. Endothelial nitric oxide synthase plays a minor role in inhibition of arterial thrombus formation.
Ozüyaman B; Gödecke A; Küsters S; Kirchhoff E; Scharf RE; Schrader J
Thromb Haemost; 2005 Jun; 93(6):1161-7. PubMed ID: 15968403
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase.
Burger D; Lei M; Geoghegan-Morphet N; Lu X; Xenocostas A; Feng Q
Cardiovasc Res; 2006 Oct; 72(1):51-9. PubMed ID: 16904088
[TBL] [Abstract][Full Text] [Related]
10. Darbepoetin-α promotes neovascularization and cell proliferation in established colorectal liver metastases.
Rupertus K; Senger S; Menger MD; Schilling MK; Kollmar O
J Surg Res; 2012 Aug; 176(2):517-23. PubMed ID: 22137989
[TBL] [Abstract][Full Text] [Related]
11. The effects of long-term smoking on endothelial nitric oxide synthase mRNA expression in human platelets as detected with real-time quantitative RT-PCR.
Shimasaki Y; Saito Y; Yoshimura M; Kamitani S; Miyamoto Y; Masuda I; Nakayama M; Mizuno Y; Ogawa H; Yasue H; Nakao K
Clin Appl Thromb Hemost; 2007 Jan; 13(1):43-51. PubMed ID: 17164495
[TBL] [Abstract][Full Text] [Related]
12. β Common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase.
Su KH; Shyue SK; Kou YR; Ching LC; Chiang AN; Yu YB; Chen CY; Pan CC; Lee TS
J Cell Physiol; 2011 Dec; 226(12):3330-9. PubMed ID: 21321940
[TBL] [Abstract][Full Text] [Related]
13. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
Morigi M; Galbusera M; Gastoldi S; Locatelli M; Buelli S; Pezzotta A; Pagani C; Noris M; Gobbi M; Stravalaci M; Rottoli D; Tedesco F; Remuzzi G; Zoja C
J Immunol; 2011 Jul; 187(1):172-80. PubMed ID: 21642543
[TBL] [Abstract][Full Text] [Related]
14. Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure.
Bahlmann FH; Song R; Boehm SM; Mengel M; von Wasielewski R; Lindschau C; Kirsch T; de Groot K; Laudeley R; Niemczyk E; Güler F; Menne J; Haller H; Fliser D
Circulation; 2004 Aug; 110(8):1006-12. PubMed ID: 15302785
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin protects critically perfused flap tissue.
Rezaeian F; Wettstein R; Amon M; Scheuer C; Schramm R; Menger MD; Pittet B; Harder Y
Ann Surg; 2008 Dec; 248(6):919-29. PubMed ID: 19092336
[TBL] [Abstract][Full Text] [Related]
16. Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db/db mice.
Cheang WS; Wong WT; Tian XY; Yang Q; Lee HK; He GW; Yao X; Huang Y
Cardiovasc Res; 2011 Nov; 92(2):267-75. PubMed ID: 21875904
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin improves skeletal muscle microcirculation through the activation of eNOS in a mouse sepsis model.
Kao RL; Martin CM; Xenocostas A; Huang W; Rui T
J Trauma; 2011 Nov; 71(5 Suppl 1):S462-7. PubMed ID: 22072004
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin delays murine platelet activation in vivo even in the absence of endothelial NO synthase.
Ni R; Peleg T; Gross PL
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2609-15. PubMed ID: 22995523
[TBL] [Abstract][Full Text] [Related]
19. Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients.
Shoji S; Inaba M; Tomosugi N; Okuno S; Ichii M; Yamakawa T; Kurihara S
Eur J Haematol; 2013 Mar; 90(3):237-44. PubMed ID: 23281632
[TBL] [Abstract][Full Text] [Related]
20. Accelerated endothelial dysfunction in mild prediabetic insulin resistance: the early role of reactive oxygen species.
Duncan ER; Walker SJ; Ezzat VA; Wheatcroft SB; Li JM; Shah AM; Kearney MT
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1311-9. PubMed ID: 17711985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
